Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies
Health Screening – Raised Cancer Markers CEA, Ca 19-9 and aFP
Comparison of the performance of total CA 19-9 and the marker panel in... | Download Table
Tumour marker CA 19-9 - Pancreatic Cancer - little known - little heeded
CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma | PLOS ONE
CA-19-9 - Diagnostic Kit
Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies
CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial - The Lancet Oncology
Old Dog, New Tricks: Use of CA 19-9 for Early Diagnosis of Pancreatic Cancer - Gastroenterology
Tumor markeri - Poliklinika Irac
Tumor Marker CA 19-9 for Assessing Pancreatic Cancer Response - Cancer Therapy Advisor
Comparison of two immunoassays for CA19-9, CEA and AFP tumor markers - Biochemia Medica
IJMS | Free Full-Text | CA 19-9 Pancreatic Tumor Marker Fluorescence Immunosensing Detection via Immobilized Carbon Quantum Dots Conjugated Gold Nanocomposite
Clinical Value of Serum CEA, CA 19-9, CA 242 and AFP in Diagnosis of Gastrointestinal Tract Cancers
CA 19-9 as a Marker for Gastrointestinal Cancers: A Review - M J Duffy, 1998
Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. | Semantic Scholar
CA 19-9 tumorski marker - Labos laboratorij Sarajevo, ul. Tešanjska br. 1
Diseases | Free Full-Text | Diagnostic and Prognostic Value of CEA and CA19- 9 in Colorectal Cancer
Tumor marker - Labpedia.net
Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas – A retrospective tumor marker prognostic study - ScienceDirect
Tumor marker debelog creva – Ca 19-9 - Millenium Medic
Positivities ofcombined tumour marker tests in patients with diseases... | Download Table
Tumour markers | PPT
